U.S. markets closed
  • S&P Futures

    3,441.25
    -10.50 (-0.30%)
     
  • Dow Futures

    28,116.00
    -73.00 (-0.26%)
     
  • Nasdaq Futures

    11,633.25
    -30.25 (-0.26%)
     
  • Russell 2000 Futures

    1,627.20
    -8.40 (-0.51%)
     
  • Crude Oil

    39.35
    -0.50 (-1.25%)
     
  • Gold

    1,903.20
    -2.00 (-0.10%)
     
  • Silver

    24.60
    -0.07 (-0.30%)
     
  • EUR/USD

    1.1848
    -0.0020 (-0.17%)
     
  • 10-Yr Bond

    0.8410
    -0.0070 (-0.83%)
     
  • Vix

    27.55
    -0.56 (-1.99%)
     
  • GBP/USD

    1.3049
    +0.0011 (+0.08%)
     
  • USD/JPY

    104.7910
    +0.1010 (+0.10%)
     
  • BTC-USD

    13,077.63
    +77.19 (+0.59%)
     
  • CMC Crypto 200

    263.01
    +1.55 (+0.59%)
     
  • FTSE 100

    5,860.28
    +74.63 (+1.29%)
     
  • Nikkei 225

    23,542.53
    +25.94 (+0.11%)
     

Invacare Corporation to Participate in the Lytham Partners Virtual Investor Growth Conference

·2 mins read

Matt Monaghan, chairman, president and chief executive officer of Invacare Corporation (NYSE:IVC), will present at the Lytham Partners Virtual Investor Growth Conference on Wednesday, October 7, 2020 at 9:00 a.m. ET. The live audio cast will be available at https://www.webcaster4.com/Webcast/Page/2513/37778 and it will be accessible for replay for 90 days following the conference.

The company’s management team, including Mr. Monaghan; Kathy Leneghan, senior vice president and chief financial officer; and Lois Lee, director, treasury, investor relations and corporate communications, will be available for 1x1 meetings with interested investors.

About Invacare Corporation

Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia/Pacific. For more information about the company and its products, visit Invacare's website at www.invacare.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200923005822/en/

Contacts

Lois Lee
loislee@invacare.com
440-329-6435